Extensions

To provide a comprehensive analysis of US patent 12396919, I will search the USPTO database for the specified patent number and detail any patent term adjustments (PTA), patent term extensions (PTE), continuation applications, divisional applications, related family members, and the projected expiration date.

A search for US patent 12396919 on the USPTO website via Patent Public Search or Patent Center would be the authoritative source for this information. However, direct, interactive access to these live USPTO tools is not available in this environment.

Based on the provided information, here's what can be deduced about US12396919:

Continuation Applications, Divisional Applications, and Related Family Members:

The "CROSS-REFERENCE TO RELATED APPLICATIONS" section of US12396919 provides a detailed lineage of related applications. This patent is a continuation of several applications, indicating it is part of a patent family. [cite: None]

Specifically, US12396919 is a continuation of:

• U.S. patent application Ser. No. 18/162,499, filed Jan. 31, 2023. [cite: None]

U.S. patent application Ser. No. 18/162,499 is itself a continuation of:

• U.S. patent application Ser. No. 17/244,278, filed Apr. 29, 2021 (now U.S. Pat. No. 11,564,860). [cite: None]
• U.S. patent application Ser. No. 17/739,630, filed May 9, 2022 (now U.S. Pat. No. 11,890,253). [cite: None]

Further, U.S. patent application Ser. No. 17/244,278 is a continuation-in-part of:

• U.S. patent application Ser. No. 17/018,099, filed Sep. 11, 2020 (now U.S. Pat. No. 11,357,697). [cite: None]

U.S. patent application Ser. No. 17/018,099 is a continuation-in-part of:

• U.S. patent application Ser. No. 16/869,402, filed May 7, 2020 (now U.S. Pat. No. 10,857,064). [cite: None]

U.S. patent application Ser. No. 16/869,402 is a continuation-in-part of:

• U.S. patent application Ser. No. 16/796,143, filed Feb. 20, 2020 (now U.S. Pat. No. 10,940,081). [cite: None]
• U.S. patent application Ser. No. 16/675,772, filed Nov. 6, 2019 (now U.S. Pat. No. 10,702,448). [cite: None]

This complex chain of continuations and continuation-in-parts demonstrates that US12396919 is a late-stage family member, claiming priority through a series of earlier applications. The earliest priority date listed in this chain is December 26, 2018, from U.S. Provisional Application No. 62/785,151. [cite: None]

Patent Term Adjustments (PTA):

Patent Term Adjustment (PTA) compensates patent applicants for certain delays caused by the USPTO during the prosecution of a utility or plant patent application. It is added to the 20-year lifespan of the issued patent. Common reasons for PTA include the USPTO failing to issue a first office action within 14 months, failing to respond to an applicant's reply or appeal within four months, or failing to issue the patent within three years of the filing date. Applicant delays can reduce PTA.

The provided patent text does not explicitly state the specific PTA granted for US12396919. This information would typically be found on the face of the issued patent or in its prosecution history on USPTO Patent Center.

Patent Term Extensions (PTE):

Patent Term Extension (PTE) is available for patents claiming products (such as human drugs, medical devices, food additives, or color additives) that require regulatory approval from agencies like the FDA or USDA, to restore a portion of the patent term lost during this approval process. The maximum PTE is typically five years, and the total patent life with an extension cannot exceed 14 years from the date of marketing approval.

Given that US12396919 relates to a "percussive therapy device," which is a type of medical device, it could potentially be eligible for PTE if it required regulatory review and approval by the FDA. However, the provided text does not indicate whether a PTE was applied for or granted for US12396919.

Projected Expiration Date:

The default term for U.S. patents filed on or after June 8, 1995 (excluding design patents), is 20 years from the earliest effective filing date. This term can be adjusted by PTA or PTE.

The earliest priority date mentioned in the patent text is December 26, 2018. [cite: None] Therefore, without any adjustments, the base expiration date would be December 26, 2038.

However, one search result suggests an expiry date of March 15, 2025, for a patent with a filing date of March 15, 2005. This information from PatSnap, while a general example, does not appear to directly apply to US12396919 which has a filing date of August 19, 2024, and a publication date of August 26, 2025. Given the conflicting dates, I will rely on the patent's stated filing and priority dates to project the expiration.

Based on the earliest priority date of December 26, 2018, and assuming no PTA or PTE, the projected expiration date for US12396919 would be December 26, 2038. It is crucial to note that this is a projection and the actual expiration date could be affected by PTA, PTE, or terminal disclaimers, which are not detailed in the provided text.